| PharmaSUG CN |
2026 |
Data Collection, Structuring, Analysis, and Reporting Considerations for CRS, ICANS, and IEC-HS in CAR-T Clinical Trials |
Zhemin Pan,
Jimmy Yang,
Shasha Hu,
Bo Li |
source |
24 |
| PharmaSUG CN |
2026 |
Interactive Clinical Plot Gallery with Cross-Plot Subject Linking in R Shiny |
You (Lea) Lyu |
source |
10 |
| PharmaSUG |
2026 |
CTCAE v6.0: The Good, the Bad, and the Ugly |
Elizabeth Dennis,
Grace Fawcett |
source |
6 |
| PharmaSUG |
2026 |
Implementing Laboratory Toxicity Grading for CTCAE Version 6 and Beyond |
Keith Shusterman,
Mario Widel |
source |
6 |
| PharmaSUG |
2026 |
The Problems Surrounding Rounding |
Jennifer McGrogan,
Mario Widel |
source |
12 |
| PHUSE APAC |
2026 |
Decoding NCI-CTCAE: Smarter Lab Grading Through Metadata and Automation |
Zulfat Kapadia |
source
presentation source |
9 |
| PHUSE EU |
2025 |
How to map lab data into the LB domain and ADLB |
Bert Parmet |
source
poster source |
6 |
| PHUSE EU |
2025 |
Leveraging Generative AI for SAS Macro Testing and Test Data Preparation |
Denis Gavriusev |
source
presentation source |
10 |
| PharmaSUG |
2025 |
Cytokine Release Syndrome (CRS) - Data Collection, Clinical Database Integration and Analyses in a Dose Escalation Cell Therapy Trial |
Cyrille Correia,
Venky Chakravarthy |
source |
13 |
| PharmaSUG |
2025 |
Decoding Laboratory Toxicity Grading: Unlocking the Potential and Overcoming Challenges of CTCAE |
Xiaoting Wu,
Lei Zhao |
source |
6 |
| PharmaSUG |
2025 |
Integration Contemplation: Considerations for a Successful ISS/ISE from Planning to Execution |
Jennifer McGrogan,
Mario Widel |
source |
8 |
| PHUSE US |
2025 |
End-to-End Therapeutic Area Data Standards Development and Governance - A Case Study Involving CRS and ICANS |
Yaling Teng |
source
presentation source |
7 |
| PharmaSUG |
2024 |
Create a Shift Summary of Laboratory Values in CTCAE Grade to the Worst Grade Abnormal Value using R and SASSY System |
Vicky Yuan |
source |
18 |
| PHUSE US |
2024 |
Addressing Challenges in Structuring CDISC SDTM and ADaM Datasets to Report Adverse Events Spanning Two Treatment Periods |
Madhusudhan Reddy Papasani |
source
presentation source |
4 |
| WUSS |
2023 |
Generation of AE (Adverse Events) summary tables by worst CTC Grade utilizing SAS |
Ballari Sen |
source |
14 |
| PharmaSUG |
2023 |
Amazing Graph Series: Butterfly Graph Using SGPLOT and GTL |
Tracy Sherman,
Aakar Shah |
source |
16 |
| PharmaSUG |
2023 |
From Sea to shining sea - End to End discussion on PR and LB data |
Abraham Yeh |
source |
7 |
| PHUSE US |
2023 |
ADAE Design for Multiple Phase Trial |
Deepak S. Grewal |
source
presentation source |
4 |
| PHUSE US |
2023 |
Data Handling of CTCAE Toxicity Grade Made Easier - A Metadata-driven Approach by SAS Macro [presentation] |
Zhaoyu Xie,
Pragathi Mudundi |
source |
18 |
| WUSS |
2022 |
Child Data Set: An Alternative Approach for Analysis of Occurrence and Occurrence of Special Interest |
Lindsey Xie,
Richann J. Watson,
Jinlin Wang,
Lauren Xiao |
source |
15 |
| PharmaSUG |
2022 |
ADaM Child Data Set: An Alternative Approach for Analysis of Occurrence and Occurrence of Special Interest |
Lindsey Xie,
Richann J. Watson,
Jinlin Wang,
Lauren Xiao |
source |
15 |
| PharmaSUG |
2022 |
From the Laboratory Toxicity Data Standardization to CTCAE Implementation |
Xiaoyin Zhong,
Jerry Xu |
source |
7 |
| PHUSE US |
2022 |
Collection, Standardization, and Reporting of Adverse Events with Toxicity Changes Using CDISC Standards in Oncology Clinical Trials |
Madhusudhan Reddy Papasani,
Swathi Kotla,
Elisabeth Pyle |
source
video
presentation source |
12 |
| PHUSE US |
2022 |
The Complexity and Magnitude of Participant Reactogenicity Data [presentation] |
Gunasekaran Subramaniam,
Katrien Van der Donck |
source
video |
21 |
| PHUSE EU |
2021 |
Utilising LSAF for Data Management at a Belgian Biotech |
Louella Schoemacher |
source
video
presentation source |
7 |
| PHUSE EU |
2020 |
ADaM is Back: The New ADaM IG 1.2 and Beyond |
Angelo Tinazzi |
source
video |
8 |
| PharmaSUG |
2020 |
How to Achieve More with Less Code |
Timothy J. Harrington |
source |
13 |
| PHUSE US |
2020 |
Adverse Event and Treatment Emergent Approaches in the Industry |
Aimee Basile |
source
poster source |
11 |
| PHUSE US |
2020 |
Get to the Bottom of Lab Toxicity Grading: Challenges and Implementation of CTCAE Version 5 |
Xiaoyin Zhong |
source
presentation source |
5 |
| PHUSE US |
2020 |
Interactive Adverse Event Data Visualization Using R Shiny |
Aditya Rachoori,
Mukul K Mittal |
source |
9 |
| PHUSE US |
2020 |
Lab Master List File Makes Easy |
Clio Wu |
source
presentation source |
7 |
| PHUSE US |
2020 |
The Misery of the Miscellaneous Folder in Module 5 |
Marguerite Kolb |
source
presentation source |
8 |
| PharmaSUG |
2019 |
Implementing Laboratory Toxicity Grading for CTCAE Version 5 |
Keith Shusterman,
Mario Widel |
source |
11 |
| PharmaSUG |
2019 |
Incremental Changes: ADaMIG v1.2 Update |
Nancy Brucken,
Brian Harris,
Terek Peterson,
Alyssa Wittle,
Deborah Goodfellow |
source |
8 |
| PharmaSUG |
2019 |
Making Lab Toxicity Tables Less Toxic on Your Brain |
Lindsey Xie,
Jinlin Wang,
Jennifer Sun,
Rita Lai,
Richann J. Watson |
source |
13 |
| PharmaSUG |
2019 |
The Anatomy of Clinical Trials Data: A Beginner's Guide |
Venky Chakravarthy |
source |
14 |
| PHUSE US |
2019 |
Effective Presentations of CTCAE-graded Laboratory Data |
William Coar,
Amber Randall |
source
presentation source |
7 |
| PHUSE US |
2019 |
Incremental Changes: ADaMIG v1.2 Update |
Brian Harris,
Deborah Goodfellow |
source
presentation source |
6 |
| PHUSE EU |
2018 |
Implementation of Data Cut Off in Analysis of Clinical Trials |
Ann Croft |
source
presentation source |
13 |
| PHUSE US |
2018 |
Incremental Changes: ADaMIG v1.2 Update |
Brian Harris,
Terek J. Peterson |
source
presentation source |
6 |
| PharmaSUG |
2018 |
Analyzing Adverse Events of Special Interest using Lab Tests and Toxicity Grades |
Vamsi Krishna Medarametla,
Liz Thomas,
Gokul Vasist |
source |
6 |
| PharmaSUG |
2018 |
Implementation of Data Cut Off in Analysis of Clinical Trials |
Mei Dey |
source |
15 |
| SGF |
2018 |
The Anatomy of Clinical Trials Data: A Beginner's Guide |
Venky Chakravarthy |
source |
14 |
| PharmaSUG |
2017 |
A Case of assessing adverse events of interest based on their grade changes |
Sriramu Kundoor |
source |
7 |
| PHUSE EU |
2016 |
Grading Lab Toxicities using NCI Common Terminology Criteria for Adverse Events (CTCAE) |
Srinivas Veeragoni,
Ankur Mathur |
source
presentation source |
10 |
| PharmaSUG |
2016 |
Lab CTCAE - the Perl Way |
Marina Dolgin |
source |
7 |
| PharmaSUG |
2016 |
SAS Macro for Summarizing Adverse Events |
Julius Kirui,
Rakesh Mucha |
source |
11 |
| PharmaSUG |
2015 |
A Practical Approach to Create Adverse Event Summary by Toxicity Grade Table |
Zhengxin (Cindy) Yang |
source |
8 |
| PharmaSUG |
2014 |
Challenges in Processing Clinical Lab Data |
Alan Meier |
source |
15 |
| PharmaSUG |
2014 |
That SASsy Lab Data |
Amie Bissonett |
source |
6 |
| PharmaSUG |
2013 |
If 'standard code' is so great ... |
Brian P. Fairfield-Carter |
source |
12 |
| PharmaSUG |
2013 |
SAS GTL: Improving Patients Safety and Study Efficiency |
Masaki Mihaila |
source |
11 |
| SGF |
2013 |
Using the ADaM ADAE Structure for Non-AE Data |
Mario Widel,
Sandra Minjoe |
source |
13 |
| SESUG |
2012 |
A SAS Macro Approach to Assign CTCAE Grades to Laboratory |
Mei Dey,
Lisa Pyle |
source |
10 |
| PharmaSUG |
2012 |
An Innovative ADaM Programming Tool for FDA Submission |
Xiangchen (Bob) Cui,
Min Chen,
Tathabbai Pakalapati |
source |
25 |
| PharmaSUG |
2010 |
Multidimensional Data Visualization for Generating Patient Profile |
Rajavel Ganesan,
Suhas R. Sanjee,
Jason Clark |
|
4 |
HOME
QUICK SEARCH
AUTHORS
KEYWORDS
HELP
BUGS